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Background: Palliative care is a policy priority internationally. In England, policymakers are seeking to develop high
quality care for all by focusing on reducing the number of patients who die in acute hospitals. It is argued that
reducing ‘inappropriate’ hospital admissions will lead to an improvement in the quality of care and provide cost
savings.
Yet what is meant by an ‘inappropriate’ admission is unclear and is unlikely to be shared by all stakeholders. The
decision process that leads to hospital admission is often challenging, particularly when patients are frail and
elderly. The ACE study reopens the idea of ‘inappropriate’ hospital admissions close to the end of life. We will
explore how decisions that result in inpatient admissions close to death are made and valued from the perspective
of the decision-maker, and will consider the implications of these findings for current policy and practice.
Design/Methods: The study focuses on the admission of patients with advanced dementia, chest disease or cancer
who die within 72 hours of admission to acute hospitals. The study uses mixed methods with three data collection
phases. Phase one involves patient case studies of admissions with interviews with clinicians involved in the
admission and next-of-kin. Phase two uses vignette-based focus groups with clinical professionals and patients
living with the conditions of interest. Phase three uses questionnaires distributed to clinical stakeholders. Qualitative
data will be explored using framework analysis whilst the questionnaire data will be examined using descriptive
statistical analysis. Findings will be used to evaluate current policy and literature.
Discussion: Significant ethical and validity issues arise due to the retrospective nature of phase one of the study.
We are not able to gain consent from patients who have died, and the views of the deceased patients cannot be
included directly, which risks privileging professional views. This phase also relies on the memories of the
participants which may be unreliable. Later phases of the study attempt to compensate for the “absent voices” of
the deceased patients by including next-of-kin and patient focus groups.
Keywords: End-of-life care, Palliative care, Place of death, Inappropriate admissions, Mixed methods, Vignettes,
Framework analysis, Social marketing, Behaviour change, EthicsBackground
Policymakers in many Western countries are attempting
to improve the quality of Palliative care and have devel-
oped strategies to help them do this [1-4]. The aim of
the English End of Life Care Strategy for example, “is to
bring about a step change in access to high quality care
for all people approaching the end of life… High quality
care should be available wherever the person may be: at
home, in a care home, in hospital, in a hospice or* Correspondence: zsm20@cam.ac.uk
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reproduction in any medium, provided the orelsewhere” [4]. Health services must attempt to im-
prove care within the context of ageing populations, in-
creasing death rates and economic constraints.
Despite policy rhetoric around improving quality of
care independent of place, the dominant policy discourse
around the problem of Palliative care centres upon place.
Acute settings are also seen as unpleasant places in
which to die [5,6], and it is argued that, as most people
express a wish to die at home, patient choice should be
met through reducing the rate of inpatient deaths. There
is a belief also that Palliative care competes unnecessar-
ily for scarce resources and could be made more cost-td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reduced in favour of deaths at home [7-9].
Policymakers are hopeful that with better access to
24-hour community care and greater staff awareness,
the number of inappropriate admissions will reduce –
with cost-savings following.
There are, however, a number of issues which chal-
lenge the validity of these assumptions and therefore
could influence the success of the policy. One is the as-
sumption that patients and carers will respond to greater
and improved opportunities for home care by making
decisions which avoid hospital admissions. How deci-
sions that lead to admissions at the very end of life are
actually made in practice is largely unknown. However,
retrospective studies suggest that recognition of a pa-
tient being near the end of life often comes late, justifi-
cations for admission (or not) are not shared amongst
stakeholders [10-13], and that clinician and informal
caregiver behaviour, and therefore behaviour change, is
guided by a complex range of factors which go beyond
training to support technical efficiency, including emo-
tion, habit, belief, and so forth [14-16]. The literature
also suggests that many patients do not have a prefer-
ence, or change their preferences away from home to
hospital as their illness progresses [17,18]. Often, a hos-
pital admission is not seen as inappropriate to a patient
or carer, but more an inevitability, even if many patients
do aspire to die at home [19-21]. Questions about the
assumptions of policy have implications for both policy
and practice.Table 1 How the research questions will be addressed by dat
Research questions Data collection
1. How are decisions that result in admissions at
end of life made in practice?
• Qualitative interviews wit
makers in the community
with next of kin of 48 pati
develop descriptive case-s
experiences
2. What do patients, carers and practitioners
think can or should be different in decision-
making around admissions to hospital close to
the end of life?
• Vignette-based focus gro
carers and commissioners/
their perspectives on acut
of life
• Qualitative vignette-style
professionals to validate an
from the interview phase
3. What is current policy around place of death
and hospital admissions close to the end of life?
• Review and evaluation o
against the empirical findi
4. How do current policy and practice compare? • Review and evaluation o
against the empirical findi
5. What are the implications for policy and
practice?
• Review and evaluation o
against the empirical findiMismatches between policy assumptions and those of
frontline carers may influence the implementation of
current policy (reducing admissions) as people are un-
likely to respond as intended. Mismatches also question
the appropriateness of current policy solutions to the
wider policy aim of increasing quality of care and enab-
ling choice of place at the end of life. For these reasons,
the ACE Study seeks to reopen the question of “inappro-
priate” or “avoidable” admissions close to the end of life.
It aims to understand the decision processes that result
in a patient being admitted to hospital where they die
soon afterwards. It is designed to explore how decisions
resulting in inpatient admissions close to death are made
and valued from the perspective of the decision-makers
themselves, and to consider the implications for policy
and practice.
[Table 1. Details the research questions, study objec-
tives and analysis].Methods and Design
Design
The study uses mixed methods. Qualitative data will
help describe how admissions are understood and
viewed from “the ground up”. Quantitative data will help
determine the extent of the attitudes, perspectives and
intentions we have gathered from the qualitative part of
the study reflect patient and practitioners experiences.
Together, these data will then be used to evaluate




ents will be used to
tudies of patient
• Thematic analysis of interview data
• Quantitative analysis of questionnaire
ups with patients/
managers to explore
e admissions at end
• Thematic analysis of interview data
• Quantitative analysis of questionnaire
questionnaires with
d quantify findings
• Thematic analysis of patient focus groups
f literature and policy
ngs
• Thematic analysis of literature and policy
• Thematic analysis of commissioner/manager
focus groups
f literature and policy
ngs
• Critical comparison of thematic analysis of
empirical data and thematic analysis of policy to
help identify overlaps, gaps, contradictions and
tensions.
f literature and policy
ngs
• Application of social marketing framework to
help identify “actionable insights” for policy and
practice.
H= Hospital C= Condition P= Participant
Figure 1 Participant structure of the study.
D =decision-maker NOK = Next of Kin
Figure 2 How participants relate to the deceased patient.
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The study focuses on two adjoining but separate admin-
istrative areas, with different demographic profiles rele-
vant to place of death, including access to services. The
first area is largely rural, with a university city and larger
towns and areas of significant social deprivation and af-
fluence. The second area is mainly urban, characterised
by high levels of ethnic diversity and significant pockets
of urban deprivation. The study area includes one large
Primary Care Trust (PCT) which will shortly become a
Clinical Commissioning Group (CCG), responsible for
purchasing care for the local communities. There are
two providers of Out of Hours (OOH) primary care and
two Local Authorities responsible for social care. The
study will focus on the two acute settings in the study
areas.
Data collection
The study is organised in three data collection phases,
encompassing five research tasks.
Phase 1: Patient case-studies
Phase 1 of the study adopts a qualitative case-study ap-
proach centred on patients aged 65 or older with advanced
dementia, Chronic Obstructive Pulmonary Disease, or
cancer who die within 72 hours of admission to of the two
hospitals. Patients will be identified retrospectively with
help from the hospitals’ Bereavement Services. These Ser-
vices receive the hospital notes and organise the death cer-
tificates and other paperwork that needs to be completed
following all deaths in hospital: the notes will be used to
identify patients for the case studies. The Services also
provide comprehensive bereavement support or onward
referral as appropriate. The study aims to identify a max-
imum of 48 patient case-studies, half from each hospital,
with approximately eight patients in each condition group.
This is shown diagrammatically in Figure 1. Patients will
be purposively sampled to ensure coverage of a range of
variables known to predict place of death [4,22].
Participants in Phase 1 are (1) community and hospital
staff involved in the admission who will be interviewed
shortly after the death and (2) patients’ next of kin, who
will be interviewed three to six months after the patient
died. Up to six people involved with each patient’s care
will be invited for interview, including one next of kin if
possible. Staff will be identified from patient medical re-
cords and then through a “chain” or snowball sampling
(See Figure 2).
The recorded next of kin in the deceased’s medical
record will be contacted by the hospitals’ bereavement
offices and invited to take part in the study. Participants
will be asked to return a reply-slip indicating interest to
the university-based research team. In both cases, data
will be collected through semi-structured interviews.The interviews are designed to explore carers’ descrip-
tions and explanations of what happened and why; the
factors that influenced the decision to admit the patient
to hospital; how they view the decision in hindsight and
what, if anything in their view, could or should have
been done differently to prevent admission. Interviews
with the next of kin will cover similar issues as well par-
ticipant’s thoughts on what the patient wanted or might
have wanted; and what, if anything, they would like to
have been different in the support given.Phase 2: Non-clinical stakeholder perspectives
Phase 2 of the study involves vignette-based focus
groups with patients and carers living with the three
conditions of interest to gain a patient perspective. Focus
groups will be organised by place and condition (n=6
groups of 6–8 participants). Participants will be identi-
fied through hospital services, support groups, the ACE
Study user group and existing patient and public in-
volvement networks. Interested participants who reply
to the research team will be invited to take part in the
study if they meet eligibility criteria.
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brief vignette story about a patient admitted to hospital
who dies shortly afterwards and, depending on time, a
patient who dies at home. Participants will be asked to
comment on issues such as: what the story tells them;
what they might expect to happen; what the people in
the story want to happen; what they expect from taking
the patient to hospital; what reasons there are for not
taking the patient to hospital; what the right thing to do
was; what alternative options there were.
A qualitative vignette approach was chosen as being
particularly well suited to supporting discussion around
topics that are “difficult to broach” or potentially upset-
ting [23], by creating distance between the participant
and the topic [24]. This approach is similar to that
employed by Gott et al. in their study of older people's
preferences for place of care at end of life [19].
We will use the same vignette approach with a group
of senior policymakers and commissioners to compare
responses. Participants will be identified through existing
professional networks and snowball sampling.Phase 3: Clinical stakeholder perspectives
In Phase 3, a vignette-style questionnaire for staff in
hospitals and the community will validate and quantify
earlier findings. The research team will compile a data-
base of relevant professionals within the National
Health Service (NHS) boundary of the area. This will in-
clude GPs, District Nurses, OOH staff, ambulance staff;
palliative care specialists in hospitals and the commu-
nity, and hospital staff who care for older people, in par-
ticular Registrars and Consultants in Geriatrics, Chest
Medicine, Oncology, and Emergency Medicine. District
Nurses will be identified though area managers, and
hospital staff through a “snowball” technique working
with departments and existing research team contacts.
Details of GPs are in the public domain. A question-
naire will be sent to everyone on the database and it is
anticipated that the sample size will be approximately
1000.
The focus of the questionnaire will include a set of pa-
tient vignettes with closed multiple-choice options about
whether the patient should be admitted or referred,
followed by open text boxes asking for reasons and com-
ments. These vignettes will be developed from case-
studies in the interview phase of the research, with further
input from clinicians and the user group. Vignette ques-
tionnaires are considered superior to a traditional ques-
tionnaire format because the questions asked are less
abstract and closer to real-life [25]. When used quantita-
tively they also allow the collection of data from large
numbers of people [24,26] and are particularly good for
exploring ill-defined issues or dilemmas [27].Analysis
Table 1 summarises how the data will be analysed to an-
swer the research questions. Data analysis will happen in
two phases. First the empirical data will be analysed. Sec-
ondly, the findings will be used to evaluate current policy
around palliative care and make policy recommendations.
Analysis of empirical data
Data from interviews will be organised thematically using
an adapted framework analysis approach [28]. This uses a
thematic template [29] and a data recording matrix of
theme against participant to identify and organise responses
for further analysis and interpretation [30]. The focus of the
analysis will be to ascertain participant’s perspective, includ-
ing their opinions, values and assumptions. This data is
likely to be gathered from indirect questioning about the
participants experience.
The analysis approach will be guided by psychological
models of behaviour and will use a social marketing
framework to help highlight key factors in decision-
making. Psychological models of behaviour change are
useful for understanding behaviour as they can help direct
analytical attention to issues that might be relevant to be-
haviour change [14,15] and are well established in health
psychology. Social cognition theories relate to how indi-
viduals make sense of social situations, recognising that
individual behaviour is influenced by a number of factors
such as a person’s belief and their self-efficacy. An ex-
ample of these models of behaviour is shown in Figure 3.
Social marketing is used in public health to help bring
about behaviour change [31]. It starts with generating
“insights” into actors’ current practices, beliefs, and pref-
erences which influence their behavioural choices. It as-
sumes that individual behaviour is premised on many
factors with trade-offs between them, and that current
practice may have benefits which are forgone if the be-
haviour is changed, such as emotional well-being and so-
cial acceptance. In Public Health research these insights
have been used to develop “attractive exchanges” [32],
designed to support the adoption of new behaviours.
Social marketing assists analysis by focusing attention
on the factors that influence behaviour from the per-
spective of the actors themselves, without attempting to
attribute blame. The current palliative care policy di-
rected towards reducing inpatient death does not ex-
plore why formal and informal caregivers decide to
admit a patient and using an analysis approach that is
focused on behaviour will provide useful insight. Apply-
ing the social marketing framework to the data will help
order the analysis and generate future policy options for
providing high quality Palliative care grounded in the
empirical data.
The questionnaire data will be analysed quantitatively,
requiring open questions to be coded. The sampling frame
Figure 3 A simplified model of behaviour [14].
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involved in decision concerning hospital admissions in the
two hospitals studied and the surrounding community
teams. We estimate this to be around 1000 professionals.
The questionnaire is not designed for hypothesis testing
and will generate primarily descriptive data. Basic descrip-
tive analysis of categorical sets such as professional group
or geographical area will be undertaken in SPSS, using
methods including chi-square, logistical regression and
cluster analysis as appropriate. Analysis categories will be
derived from the literature and cluster analysis. Question-
naire results will be collated with the main qualitative ana-
lysis and used to evaluate current policy and make
recommendations.
The second stage of the analysis will evaluate current
policy and literature in the light of the empirical find-
ings. We expect that combining the behaviour model
and social marketing framework will provide powerful
analytical leverage to offer a clear description of current
behaviour and its associates, and a transparent means to
evaluate current policy. This analysis is intended to be
solution-focused; to provide “actionable insights” to in-
form effective policy.
Ethical issues
Palliative care is recognised as a sensitive area to research.
As such, a considerable time has been spent discussing
the protocol and instruments with clinician stakeholders
and the user group, who have advised on feasibility and
acceptability. A central issue was the identification of suit-
able patients and the individuals who had been involved
in the decision which had led to their admission tohospital. Consent could not be gained from the deceased
patient and neither was proxy consent from next of kin
possible. This was both because a patient's notes remain
confidential to the patient after death and because our
user group advised against contacting bereaved relatives
so soon after death. Instead we gained approval from the
National Information Governance Board (NIGB) to view
deceased patients’ records to collect relevant information
and identify an initial contact. In addition we have collab-
orated with the hospital bereavement services who will
initially approach next of kin and invite them to partici-
pate in the study.
Working with the bereavement services is beneficial to
maintaining the confidentiality of participants. In par-
ticular, the invitation letter to the patient’s next of kin
will come from the care provider, thus ensuring patient
and personal data remains within the service. In turn,
the service will not know who responded to the research
team, which will help increase the anonymity of the
responses.
It is usual when undertaking research with people
who have been bereaved or who are very ill to inform
participants that you will contact their GP on their be-
half if they become worryingly distressed during the
interview and refuse to seek help themselves. In this
case, the participants are not known to the researchers
as patients, so it will be necessary to gather information
about the participants’ GP before they are interviewed.
The research ethics committee reviewing the study also
requested that the interviewer follow up next of kin par-
ticipants a couple of days after interview to check on
their well-being. In addition we were asked to prepare
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port to leave with participants.
The topic of care at the end of life is potentially very
emotionally charged for all participants: care profes-
sionals who may have regrets over decisions made, and
informal carers who are recently bereaved. However,
since care in last few days of life is the focus of the
study, we have been explicit in our material to ensure
that participants are not surprised by this topic being
raised. While this may bias the sample, this approach we
believe is more ethical and is unlikely to be detrimental
to overall validity of the study.
The vignette design of the focus groups will allow par-
ticipants to distance themselves from the topic if they
wish. The focus groups with patients and carers will be
attended by two researchers, so that one can support
any participant should they become distressed. At their
own suggestion, members of the project's user group
have volunteered to attend the focus groups to help sup-
port and reassure participants. At the end of the focus
group participants will be debriefed and asked if they
have any concerns arising from the group session. They
will be signposted to contacts from where they could
gain support. We will seek to arrange for an appropriate
specialist nurse to come at the end of the group session
to take any questions and help debrief participants.
Approvals
The study is approved by the Hertfordshire Research Ethics
Committee (England) (#11/EE/0491), and National Infor-
mation Governance Board (NIGB) (ECC 1–05 (g)/2012).
Discussion
The ACE Study faces a number of challenges.
1) There are ethical and data protection issues related
to the impossibility of obtaining patient consent and
the sensitive nature of the topic. Resolving these has
added layers of research ethics and governance
processes and delayed the study by about six
months. This has been very challenging as the study
has a finite end date due to funding.
2) The retrospective design of Phase 1 necessarily
excludes patients and may therefore privilege
professional views. We have attempted to
compensate for this by including bereaved carers/
family, as recipients of care themselves as well as
patient proxies. Whilst imperfect, this is a
commonly used strategy in palliative care research
[33]. In addition, retrospective studies using proxies
can illuminate the experiences of people who died
but were not previously identified as “end of life”
and those who would have been too ill to take part
themselves [34].3) Including next of kin in the design presents
additional ethical challenges. If attempts are made to
protect participants, and bereaved relatives in
particular, they are excluded and patronised [35].
There is a balance between autonomy and non-
maleficence [36,37]. The ACE Study has attempted
to include people and offer support without
assuming they cannot cope, in which we are guided
by existing models of acceptable practice [38].
4) The absent voice of the patient is brought in
through focus groups with patient and carer groups
in Phase 2. Vignettes will be used to place distance
between the participants’ personal experience and
the discussion [19]. Tang’s study of preferences of
people with dementia and their carers show that the
need to make choices about care at end of life is one
of the strongest sources of emotional distress [39].
The vignettes will help participants through this
without reference to their choice.
5) For some there will also be concerns about the
validity of the data, particularly in the first phase
which is retrospective and asks participants to recall
what happened. It can be argued that memories are
unreliable sources of description of what actually
happened, made more insubstantial by
reinterpretation through hindsight and social
desirability. We will attempt to speak to
professionals as soon after the death as possible
(aiming for within two weeks) to assist recall.
However, the process of interviewing can also be
viewed as an essential element of sense-making,
reflection and learning [40] through the
development of “narratives” [41] Interpretation,
reflection and learning are more likely to guide
future action than forgotten “truths”. Their accounts
will also reveal the context of the decision-making
process. Participants will articulate what they
considered pertinent in the decision, and thus will
reveal attitudes and values that inform decision-
making at the end of life.
Despite these limitations, the ACE Study will provide a
unique descriptive account of the decision-pathway that
ends with an inpatient death soon after admission, how
these are understood and valued by stakeholders, and
what this means for policy and practice. A summary of
how the study will add to existing knowledge is
presented below.
The ultimate aim is to provide knowledge that can be
used to improve patient care. Better insight into the pro-
cesses and reasons for current decisions concerning hos-
pital admissions close to death can support better
targeting of effort to improve the quality of palliative care.
These questions and themes are relevant to policymakers
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currently seeking to reduce hospital admissions close to
the end of life and increase the number of deaths that
occur at home, while at the same time as enabling choice
and “a good death”. The ACE Study will help confirm
whether these aspirations align or not, and highlight some
future options for policy and practice.
Summary of how the study will add to existing
knowledge
What the study will add
 Understanding of the end of life care decision-
making for the patients with non-malignant as well
as malignant diseases.
 Understanding of decision-making “in context” and
around an actual critical event, rather than a
hypothetical (improved ecological validity).
 Multiple perspectives on the same admission
revealing issues relevant to the health care system,
including views of informal carers and non-specialist
palliative care clinicians.
 An empirically-derived model of actual decision-
making about admission at the very end of life to
inform policy and practice.
 An empirically-derived definition of “inappropriate”
admissions.
 Applied, solution-focused approach designed to
support policy and service development.
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